Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes

Endocrinology and Metabolism Clinics of North America

Volumn 41, Issue 1, 2012, Pages 25-39

  Ferrannini, Ele ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Glucose homeostasis; Insulin therapy; Type 1 diabetes; Type 2 diabetes

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

DIET RESTRICTION; DOSE RESPONSE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; GLYCOGENOLYSIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFUSION RATE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; INSULINEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; INSULIN RESISTANCE;

EID: 84860625777     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2012.01.003     Document Type: Review

References (49)

1. Leibiger I.B., Leibiger B., Berggren P.O. Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr 2008, 28:233-251.
2. Mari A., Tura A., Natali A., et al. Influence of hyperinsulinemia and insulin resistance on in vivo β-cell function: their role in human β-cell dysfunction. Diabetes 2011, 60(12):3141-3147.
3. Bouche C., Lopez X., Fleischman A., et al. Insulin enhances glucose-stimulated insulin secretion in healthy humans. Proc Natl Acad Sci U S A 2010, 107:4770-4775.
4. Kawamori D., Kurpad A.J., Liew C.W., et al. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab 2009, 9:350-361.
5. Ferrannini E., Muscelli E., Natali A., et al. Association of fasting glucagon and proinsulin concentrations with insulin resistance. Diabetologia 2007, 50:2342-2347.
6. Gastaldelli A., Baldi S., Pettiti M., et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 2000, 49:1367-1373.
7. Natali A., Toschi E., Camastra S., et al. Determinants of postabsorptive endogenous glucose output in non-diabetic subjects. Diabetologia 2000, 43:1266-1272.
8. Cherrington A.D., Chiasson J.L., Liljenquist J.E., et al. Control of hepatic glucose output by glucagon and insulin in the intact dog. Biochem Soc Symp 1978, 43:31-45.
9. Cherrington A.D., Edgerton D., Sindelar D.K. The direct and indirect effects of insulin on hepatic glucose production in vivo. Diabetologia 1998, 41:987-996.
10. Cherrington A.D. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 1999, 48:1198-1214.
11. Cherrington A.D., Moore M.C., Sindelar D.K., et al. Insulin action on the liver in vivo. Biochem Soc Trans 2007, 35:1171-1174.
12. Ferrannini E., Wahren J., Faber O.K., et al. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol 1983, 244:E517-E527.
13. Byrne M.M., Sturis J., Polonsky K.S. Insulin secretion and clearance during low-dose graded glucose infusion. Am J Physiol 1995, 268:E21-E27.
14. Ferrannini E., Cobelli C. The kinetics of insulin in man. II. Role of the liver. Diabetes Metab Rev 1987, 3:365-397.
15. Lefèbvre P.J. Glucagon and its family revisited. Diabetes Care 1995, 18:715-730.
16. Cherrington A.D. Central versus peripheral glucose sensing and the response to hypoglycemia. Diabetes 2008, 57:1158-1159.
17. Ramnanan C.J., Saraswathi V., Smith M.S., et al. Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs. J Clin Invest 2011, 121:3713-3723.
18. Ferrannini E., Groop L.C. Hepatic glucose production in insulin-resistant states. Diabetes Metab Rev 1989, 5:711-726.
19. DeFronzo R.A., Ferrannini E., Hendler R., et al. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 1983, 32:35-45.
20. Prager R., Wallace P., Olefsky J.M. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest 1986, 78:472-481.
21. DeFronzo R.A., Ferrannini E., Simonson D.C. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989, 38:387-395.
22. DeFronzo R.A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
23. Ferrannini E., Gastaldelli A., Iozzo P. Pathophysiology of prediabetes. Med Clin North Am 2011, 95:327-339.
24. DeFronzo R.A., Simonson D., Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1982, 23:313-319.
25. Ferrannini E., Wahren J., Felig P., et al. The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. Metabolism 1980, 29:28-35.
26. Iozzo P., Hallsten K., Oikonen V., et al. Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control. J Clin Endocrinol Metab 2003, 88:2055-2060.
27. Modigliani R., Bernier J.J. Absorption of glucose, sodium, and water by the human jejunum studied by intestinal perfusion with a proximal occluding balloon and at variable flow rates. Gut 1971, 12:184-193.
28. Petrides A.S., Vogt C., Schulze-Berge D., et al. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994, 19:616-627.
29. Polonsky K.S., Given B.D., Hirsch L.J., et al. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 1988, 318:1231-1239.
30. Holst J.J. The physiology of glucagon-like peptide 1. Physiol Rev 2007, 87:1409-1439.
31. Waldhäusl W.K., Gasic S., Bratusch-Marrain P., et al. The 75-g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man. Diabetologia 1983, 25:489-495.
32. Ferrannini E., Bjorkman O., Reichard G.A., et al. The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes 1985, 34:580-588.
33. Waldhäusl W.K., Gasic S., Bratusch-Marrain P., et al. Effect of stress hormones on splanchnic substrate and insulin disposal after glucose ingestion in healthy humans. Diabetes 1987, 36:127-135.
34. Burcelin R. The gut-brain axis: a major glucoregulatory player. Diabetes Metab 2010, 36(Suppl 3):S54-S58.
35. Nauck M.A., Vardarli I., Deacon C.F., et al. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?. Diabetologia 2011, 54:10-18.
36. Nauck M., Stöckmann F., Ebert R., et al. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 1986, 29:46-52.
37. Muscelli E., Mari A., Casolaro A., et al. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 2008, 57:1340-1348.
38. Firth R.G., Bell P.M., Marsh H.M., et al. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest 1986, 77:1525-1532.
39. Vella A., Shah P., Basu A., et al. Prandial insulin and the systemic appearance of meal-derived glucose in people with type 1 diabetes. Diabetes Care 2008, 31:2230-2231.
40. Tengholm A., Gylfe E. Oscillatory control of insulin secretion. Mol Cell Endocrinol 2009, 297:58-72.
41. Polonsky K.S., Sturis J., Van Cauter E. Temporal profiles and clinical significance of pulsatile insulin secretion. Horm Res 1998, 49:178-184.
42. Caumo A., Luzi L. First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 2004, 287:E371-E385.
43. O'Rahilly S., Turner R.C., Matthews D.R. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 1988, 318:1225-1230.
44. Pørksen N., Hollingdal M., Juhl C., et al. Pulsatile insulin secretion: detection, regulation, and role in diabetes. Diabetes 2002, 51(Suppl 1):S245-S254.
45. Ferrannini E., Massari M., Nannipieri M., et al. Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study. Diabetologia 2009, 52:818-824.
46. Walker M., Mari A., Jayapaul M.K., et al. Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects. Diabetologia 2005, 48:2470-2476.
47. Ferrannini E., Natali A., Muscelli E., et al. on behalf of the RISC Investigators. Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia 2011, 54:1507-1516.
48. Rahier J., Guiot Y., Goebbels R.M., et al. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008, 10(Suppl 4):32-42.
49. Henquin J.C., Rahier J. Pancreatic alpha cell mass in European subjects with type 2 diabetes. Diabetologia 2011, 54:1720-1725.